AHRQ Patient Safety Network

Relenza (zanamivir) inhalation powder.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.

This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.

Information

Letter (PDF)

Related Resources

PRESS RELEASE/ANNOUNCEMENT

Serious medication errors from intravenous administration of nimodipine oral capsules.

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; August 2, 2010.

NEWSPAPER/MAGAZINE ARTICLE

Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment.

ISMP Medication Safety Alert! Acute Care Edition. August 11, 2011;16:1-3.

COMMENTARY

Unintended transplantation of three organs from an HIV-positive donor: report of the analysis of an adverse event in a regional health care service in Italy.

Bellandi T, Albolino S, Tartaglia R, Filipponi F. Transplant Proc. 2010;42:2187-2189.

NEWSPAPER/MAGAZINE ARTICLE

Preventing catheter/tubing misconnections: much needed help is on the way.

ISMP Medication Safety Alert! Acute Care Edition. July 15, 2010;15:1-2.

View all related resources...

Download: Adobe Reader email icon

Find Related Resources by...

Resource Type

Press Release/Announcement

Target Audience

Health Care Providers

Risk Managers

Quality and Safety Professionals

Clinical Area

Infectious Diseases

Safety Target

Device-related Complications

Administration Errors

Error Types

Active Errors

Approach to Improving Safety

Reminders

Education and Training

Origin/Sponsor

Food and Drug Administration (FDA)